Back to Search Start Over

Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) study.

Authors :
Olafsson, Sigurdur
Love, Thorvardur Jon
Fridriksdottir, Ragnheidur Hulda
Tyrfingsson, Thorarinn
Runarsdottir, Valgerdur
Hansdottir, Ingunn
Bergmann, Ottar Mar
Björnsson, Einar Stefan
Johannsson, Birgir
Sigurdardottir, Bryndis
Löve, Arthur
Baldvinsdottir, Guðrún Erna
Thordardottir, Marianna
Hernandez, Ubaldo Benitez
Heimisdottir, Maria
Hellard, Margaret
Gottfredsson, Magnus
Source :
International Journal of Drug Policy. Nov2024, Vol. 133, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

• Limited data exists about treatment outcomes in nationwide HCV elimination programs where injection drug use is the main mode of transmission. • In 2016 Iceland initiated the HCV elimination program known as treatment as prevention for Hepatitis C (TraP HepC). • History of injection drug use was reported by 84 % and 33 % had injected recently. • By reengagement in care and prompt retreatment when needed, a cure rate of 95.5 % was achieved. • Unstable housing was the only independent factor associated with not achieving cure. Limited data exists about treatment outcomes in nationwide hepatitis C virus (HCV) elimination programs where injection drug use (IDU) is the main mode of transmission. In 2016 Iceland initiated the HCV elimination program known as Treatment as Prevention for Hepatitis C (TraP HepC). Factors associated with HCV cure in this population are examined. Unrestricted access was offered to direct acting antiviral agents (DAAs). Testing and harm reduction was scaled up and re-treatments were offered for those who did not attain cure. Cure rates for the first 36 months were assessed and factors associated with failure to achieve cure analysed using multivariable logistic regression. Treatment was initiated for 718; 705 consented for the study. Median age was 44 years (IQR 35–56), history of IDU reported by 593 (84.1 %), recent IDU by 234 (33.2 %); 48 (6.8 %) were homeless. Of 705 patients, 635 achieved cure (90.1 %) during the first treatment. A total of 70 (9.9 %) patients initiated two or more treatments, resulting in 673 participants cured (95.5 %). By multivariable analysis, homelessness was the only statistically significant independent factor associated with not achieving cure (OR 2.67, 95 % CI 1.32–5.41) after first treatment attempt. By reengagement in care and prompt retreatment when needed, a cure rate of 95.5 % was achieved. Unstable housing, a potentially actionable factor is associated with poor outcome. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09553959
Volume :
133
Database :
Academic Search Index
Journal :
International Journal of Drug Policy
Publication Type :
Academic Journal
Accession number :
180653259
Full Text :
https://doi.org/10.1016/j.drugpo.2024.104616